22 Indian tech startups debuted on public markets in FY26, reporting an average revenue growth of 35% across the cohort. This represents the largest single-year wave of tech IPOs, putting their post-listing financial health under intense scrutiny. Public investors are now evaluating whether this growth is sustainable or a sign of premature market entry for many.
How We Got Here
After the IPO wave of FY24-FY25, featuring exits like Zomato and Nykaa, public markets became a viable path for late-stage Indian tech. This trend accelerated in FY26 as venture capital firms pushed for exits, especially as private funding became tighter post-FY23.
The Numbers
- 7 of the 22 newly listed companies achieved positive EBITDA in FY26, with the median EBITDA loss across the cohort hitting ₹75 crore.
- FinTech and SaaS startups made up 15 of the 22 public debuts, though only five from these sectors reported a year-on-year profit.
- Bengaluru-based D2C brand, HealthHub, saw its stock price decline 25% post-listing, despite achieving 60% revenue growth in FY26.
- The collective operating cash burn for these companies totalled ₹1,200 crore in FY26, a 15% increase from the previous fiscal year.
- By March 2026, 11 companies were trading below their IPO offer price, with an average valuation markdown of 18% from their debut.
What Happens Next
🇮🇳 Why This Matters for India
For founders and VCs in Mumbai and Hyderabad, these FY26 results will recalibrate late-stage private valuations and accelerate the demand for clearer profitability roadmaps.
The Take
The core lesson here for founders: India's public markets are no longer funding growth at any cost. Expect a sustained investor shift towards demonstrable unit economics and predictable cash flows for any tech IPO aiming for an FY27 or FY28 debut.
Source:
Inc42 ↗